Hints and tips:
Related Special Reports
...Formerly known as NASH, the condition is estimated to affect 115mn people worldwide and more than a third of people with obesity. It can lead to cirrhosis, a permanent scarring of the liver....
...The government unveiled plans earlier this year for £150mn of investment in the biobank, whose data has already been used by drugs companies including AstraZeneca and Johnson & Johnson....
...An online profile for The Conference Board think-tank, which retained Stones as a senior adviser, described him as being “instrumental in developing government and research partner relationships” with a...
...He said Lilly had benefited from its strong research culture and breakthroughs in the two biggest untapped pharmaceutical markets....
...These diabetes treatments are part of a drug class known as GLP-1 agonists. Recently these have been used to treat weight loss, often off-label....
...The chance conversation formalised a months-long collaboration in 2017 that eventually produced an architecture for processing language, known simply as the “transformer”....
...Ministers have also committed to the East-West rail link, connecting Oxford and Cambridge via the distribution centre of Milton Keynes, reviving the idea of what was formerly known as the Varsity Railway...
...Hannah Kuchler is the FT’s global pharmaceutical editor Follow @FTMag to find out about our latest stories first...
...included Belgian pharmaceutical subsidiary Janssen and US drug group Merck....
...Recently, the US regulator has shown it is open to considering versions of drugs better-known for their recreational properties, approving Johnson & Johnson’s drug based on ketamine for treatment-resistant...
...structure, known as an energy transition mechanism (ETM), to support Vietnam, Indonesia and the Philippines through the decarbonisation process....
...for Retail Research think-tank....
...Last year it published research showing the presence of benzene, a known human carcinogen, in sunscreen and body sprays leading to numerous product recalls by manufacturers, including Johnson & Johnson....
...Janssen, the pharmaceuticals division of J&J, and Pfizer both started their phase 3 trials in September last year....
...Extracts from his discussion with Alix Steel and Guy Johnson: AS: Were you aware of this risk when using the platform?...
...“Multiple positive developments alongside a clear path set towards reopening warrant an upgrade,” they wrote in a research report....
...Both Johnson & Johnson and Novavax have said their vaccines were less effective against the strain in clinical trials conducted in South Africa....
...But while these developments will have been disappointing to Wood’s legions of fans, the sell-off will have come as no surprise to a team of investment academics: their latest research suggests that investors...
...These companies spent $47bn on research and development over the 30 months, as well as issuing $14bn in new stock....
...Mathai Mammen, global head of Janssen Research & Development at Johnson & Johnson, said the company looked forward to “discussing with public health officials a potential strategy for our Johnson & Johnson...
...Mathai Mammen, global head of Janssen Research & Development at Johnson & Johnson, said: “We look forward to discussing with public health officials a potential strategy for our Johnson & Johnson Covid-19...
...She is now head of R&D at ViiV Healthcare, an HIV-focused pharmaceuticals company majority-owned by GlaxoSmithKline with Pfizer and Shionogi as shareholders....
...While adenovirus vector vaccines such as the Oxford/AstraZeneca and Johnson & Johnson jabs are also fairly easy to adapt, they are far trickier to scale up....
...US biotech company Vaxxinity has raised the prospect of breakthroughs in treating Alzheimer’s and Parkinson’s as a result of the unprecedented resources and energy channelled into vaccine research since...
...to grow hemp, and had developed a patented new method for extracting CBD since winning a research and development licence....
International Edition